drugset / Trial / NCT00683995
A Phase III Clinical Study of KW-2246
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to assess the safety and efficacy of long-term KW-2246 treatment as rescue medication for breakthrough pain.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-07
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | — | — |
Indications
No indication recorded.